Microbot MedicalFRA:CY9D 30 Gross Margin % is 2.20% as of Mar. 2026. GuruFocus rates FRA:CY9D with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Microbot Medical ranks worse than 95.9% on this metric.
The historical rank and industry rank for Microbot Medical's Gross Margin % or its related term are showing as below:
FRA:CY9D'
s Gross Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.91
Current: 1.91
During the past 13 years, the highestGross Margin % of Microbot Medical was 1.91%. The lowest was 0.00%. And the median was 0.00%.
FRA:CY9D's Gross Margin % is ranked worse than 95.9% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs FRA:CY9D: 1.91
Microbot Medical had a gross margin of 2.20% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Microbot Medical was 0.00% per year.
Microbot Medical (FRA:CY9D) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Microbot Medical had a gross margin of 2.20% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Microbot Medical Gross Margin % Related Terms
Microbot Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Microbot Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CY9D vs STXS, POCI, DXR: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Microbot Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Microbot Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Microbot Medical (FRA:CY9D) has a Gross Margin % of 2.20% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Microbot Medical and its competitors. According to the industry distribution chart, Microbot Medical ranks #772 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 95.9%.
Is Microbot Medical's Gross Margin % too high?
Microbot Medical's current Gross Margin % is 2.20%. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Microbot Medical's value of 2.20% is 95.8% below this industry median. Based on the distribution chart, Microbot Medical ranks #772 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Microbot Medical has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Gross Margin % compare to STXS and POCI?
According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #772 out of 805 companies for Gross Margin %. This places Microbot Medical in the lower half of its industry. The industry median Gross Margin % is 52.03. Microbot Medical's value of 2.20% is 95.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microbot Medical's current Gross Margin % of 2.20% is 95.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Microbot Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbot Medical's current Gross Margin % is 2.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (FRA:CY9D) has a current Gross Margin % of 2.20%. The current Gross Margin % is 2.20% and 95.8% below the Medical Devices & Instruments industry median of 52.03. Microbot Medical's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current Gross Margin % is 2.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
30GF Score
Get the complete analysis for FRA:CY9D
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CY9D has been successfully added to your 
